The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
Hear how the revenue cycle can impact your supply chain when embarking on a new software implementation or integration
On-Demand Educational Webinars
Advocate Health Care developed a provider-supplier partnership that reduced re-admission rates and improved quality of care inside and outside of the…
Podcasts
Michael Neely introduces the topic of risk sharing as it is becoming more popular in healthcare and how it can improve patient care while lowering
Podcasts
In this short webcast, Chris Wiekert will take you through the steps he used to lead his department in a culture change from one with poor service
Podcasts
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI.
Podcasts
Explore the new delivery methods of health care, how community resources and organizations are now working together to reduce patient episodic care